Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

GAIA-Health: microbiome suite for personalized medicine

Project description

Cutting-edge omics tool for personalised microbiome analysis

Microbiome analysis can provide diagnosis and prognosis for various diseases, including cancer, Crohn’s disease, metabolic disorders, reproductive health and skin pathologies, infections, as well as autoimmune, respiratory and mental diseases. However, the high cost and the complexity of microbiome data analysis prevents its broader adoption in personalised medicine and diagnostics. Spanish Sequentia Biotech SL has developed a cutting-edge omics tool to detect, quantify and evaluate the biological composition of any type of human microbiome sample (gut, skin, mouth, biofluids). During the EU-funded GAIA-Health project, a feasibility study will be conducted for this multi-diagnostic system that promises customised microbiome analysis with superior precision and detection power for fast and effective personalised therapies.

Objective

GAIA-Health: microbiome suite for personalized medicine
Genomic revolution is transforming our approach to treat patients by individualizing treatments that reduce adverse events and in turn decrease health care costs. Microbiome analysis can in fact be used for diagnosis and potentially prognosis of various diseases such as cancer, Crohn’s disease, metabolic disorders, reproductive health and skin pathologies and infections, as well as autoimmune, respiratory and mental diseases. Due to its broad adoption in a variety of medical and biotech domains, the global human microbiome market is witnessing an annual growth rate (CAGR) of 18,5%.
However, the the cost and the complexity of microbiome data analysis and management represents the main bottleneck in this market, preventing a broader adoption of personalized medicine and diagnostic, as well as the discovery of new therapeutic targets where there is a lack of treatments for specific diseases.
Our product - GAIA Health - bridges the gap between data production and interpretation in the health, diagnostic and biotech sector. Gaia-Health is a cutting edge omics tool that is able to detect, quantify and evaluate the biological composition of any type of sample of human microbiome (gut, skin, mouth and biofluid). GAIA Health offers unique insights into human health. It is the solution for every customer who needs customized microbiome analysis with superior precision and detection power, for faster, easier and effective personalized medicine, treatments and therapies. GAIA-Health stands apart from its competitors because of its superior precision and detection power; a Multi-diagnosis system - for this first type Gut, Skin, Mouth and Reproductive Health Analysis in one suite; and its Immediately actionable results, allowing faster and more reliable decision making .

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

SEQUENTIA BIOTECH SL
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
COMTE D'URGELL 240 3 D
08036 Barcelona
Spain

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0